I agree that this site is using cookies. You can find further informations here.
X
Hajbi, Farid EL
82  results:
Search for persons X
?
1

Atezolizumab plus modified docetaxel, cisplatin, and fluoro..:

Kim, Stefano ; Ghiringhelli, Francois ; de la Fouchardière, Christelle...
The Lancet Oncology.  25 (2024)  4 - p. 518-528 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Nivolumab plus chemotherapy or ipilimumab versus chemothera..:

Kato, Ken ; Doki, Yuichiro ; Chau, Ian...
Cancer Medicine.  13 (2024)  9 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
3

Second-line treatment after docetaxel, cisplatin and 5-fluo..:

Stouvenot, Morgane ; Meurisse, Aurélia ; Saint, Angélique...
European Journal of Cancer.  162 (2022)  - p. 138-147 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second L..:

Evrard, Camille ; Aparicio, Thomas ; Soularue, Emilie...
Biomedicines.  10 (2022)  5 - p. 1211 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mD..:

Kim, Stefano ; Boustani, Jihane ; Vernerey, Dewi...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
6

Avelumab versus standard second line treatment chemotherapy..:

Taïeb, Julien ; André, Thierry ; El Hajbi, Farid...
Digestive and Liver Disease.  53 (2021)  3 - p. 318-323 , 2021
Link: https://doi.org/10.1016/..
 
?
7

FOLFIRINOX relative dose intensity and disease control in a..:

Vary, Antonin ; Lebellec, Loïc ; Di Fiore, Frédéric...
Therapeutic Advances in Medical Oncology.  13 (2021)  - p. 175883592110298 , 2021
Link: https://doi.org/10.1177/..
 
?
8

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid EL...
Digestive and Liver Disease.  53 (2021)  4 - p. 420-426 , 2021
Link: https://doi.org/10.1016/..
 
?
9

FOLFIRINOX De-Escalation in Advanced Pancreatic Cancer: A M..:

Chevalier, Hortense ; Vienot, Angélique ; Lièvre, Astrid...
The Oncologist.  25 (2020)  11 - p. e1701-e1710 , 2020
Link: https://doi.org/10.1634/..
 
?
10

Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspas..:

Hammel, Pascal ; Portales, Fabienne ; Mineur, Laurent...
European Journal of Cancer.  130 (2020)  - p. 275-276 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Pooled analysis of 115 patients from updated data of Epitop..:

Kim, Stefano ; Meurisse, Aurélia ; Spehner, Laurie...
Therapeutic Advances in Medical Oncology.  12 (2020)  - p. 175883592097535 , 2020
Link: https://doi.org/10.1177/..
 
?
12

Erythrocyte-encapsulated asparaginase (eryaspase) combined ..:

Hammel, Pascal ; Fabienne, Portales ; Mineur, Laurent...
European Journal of Cancer.  124 (2020)  - p. 91-101 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Atezolizumab plus modified docetaxel-cisplatin-5-fluorourac..:

Kim, Stefano ; Buecher, Bruno ; André, Thierry...
BMC Cancer.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
14

Anti-epidermal growth factor receptor therapy in combinatio..:

Vendrely, Véronique ; Lemanski, Claire ; Gnep, Khemara...
Radiotherapy and Oncology.  140 (2019)  - p. 84-89 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy..:

Kim, Stefano ; Jary, Marine ; André, Thierry...
BMC Cancer.  17 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
1-15